|
|
|
|
|
by refurb
2437 days ago
|
|
Two things: 1) The largest private insurers in the US cover more people than many single payer countries, like Canada for example. They don’t get better prices. 2) As someone who works in the drug industry, Trump is actually the first President in recent history that is freaking out the pharma companies. His “international price referencing” proposal is being taken very seriously as it would have very negative consequences. |
|
Private insurers aren't motivated to do any of this because high drug prices don't hurt their bottom line.